background
rhinoviru
rv
major
caus
respiratori
infect
human
impos
enorm
econom
burden
due
direct
indirect
cost
associ
ill
accur
time
diagnosi
crucial
decid
appropri
clinic
approach
minim
unnecessari
prescript
antibiot
diagnosi
rv
extrem
challeng
due
genet
serolog
variabl
among
numer
type
similar
enterovirus
object
sought
develop
rapid
nucleic
acid
test
use
detect
rhinoviru
within
laboratori
near
patient
set
studi
design
develop
evalu
novel
isotherm
nucleic
acid
amplif
method
call
revers
transcript
strand
invasionbas
amplif
rtsiba
rapidli
detect
rhinoviru
clinic
specimen
result
method
rtsiba
detect
rv
clinic
specimen
high
analyt
sensit
specif
time
posit
result
significantli
shorter
rv
rtsiba
assay
refer
rv
nucleic
acid
amplif
method
rtqpcr
conclus
rapid
detect
time
rv
siba
assay
well
compat
portabl
instrument
facilit
prompt
diagnosi
infect
therebi
improv
patient
care
upper
respiratori
tract
infect
urti
includ
common
cold
preval
human
ill
rhinovirus
rv
respons
onehalf
urti
jacob
et
al
megremi
et
al
rv
positivesens
singlestrand
rna
virus
belong
genu
enteroviru
famili
picornavirida
rv
compris
three
speci
rhinoviru
b
c
type
within
commonli
refer
speci
letter
number
eg
rhinoviru
date
rhinoviru
type
identifi
display
high
genet
antigen
variabl
megremi
et
al
tapparel
et
al
rv
infect
carri
enorm
econom
burden
due
direct
indirect
cost
associ
ill
addit
caus
common
cold
virus
caus
agent
mani
case
sever
pneumonia
elderli
immunocompromis
patient
well
exacerb
chronic
obstruct
pulmonari
diseas
asthma
jacob
et
al
tan
et
al
wark
et
al
moreov
rhinoviru
infect
increas
suscept
bacteri
infect
eg
disrupt
epitheli
cell
barrier
function
promot
bacteri
adhes
intern
epithelia
sajjan
et
al
unger
et
al
respiratori
infect
caus
varieti
viral
bacteri
pathogen
accur
time
diagnosi
crucial
optim
manag
treatment
diagnosi
rv
challeng
due
genet
antigen
variabl
among
type
well
present
similar
sign
symptom
patient
infect
bacteri
viral
respiratori
pathogen
furthermor
rhinovirus
grow
slowli
cell
cultur
rvc
current
uncultiv
price
lau
et
al
develop
serologyand
antibodybas
detect
method
hamper
due
structur
divers
rv
type
slow
immun
respons
gener
specif
antibodi
thu
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
remain
sensit
method
diagnosi
rv
et
al
dagher
et
al
rtpcr
often
target
highli
conserv
noncod
region
ncr
rv
type
rv
ncr
howev
rv
ncr
region
highli
similar
enteroand
rhinovirus
rtpcr
method
distinguish
rhinovirus
member
enteroviru
genu
cassandra
et
al
consequ
commerci
rv
rtpcr
test
report
combin
result
rhinoviru
enteroviru
furthermor
rtqpcr
requir
thermal
cycler
skill
personnel
costli
requir
laboratori
environ
limit
use
field
pointofcar
applic
isotherm
nucleic
acid
amplif
method
obviat
need
thermal
cycler
reaction
perform
low
constant
temperatur
studi
develop
isotherm
nucleic
acid
amplif
method
detect
rv
method
reversetranscript
strand
invasionbas
amplif
rtsiba
previous
shown
use
diagnosi
infecti
diseas
eboigbodin
et
al
eboigbodin
et
al
b
rtsiba
reaction
rna
first
revers
transcrib
cdna
immedi
amplifi
detect
isotherm
reaction
condit
fig
siba
method
reli
separ
target
duplex
recombinaseco
invas
oligonucleotid
io
allow
primer
bind
dna
polymeras
extend
target
sequenc
continu
strand
separ
primer
extens
lead
exponenti
amplif
target
rna
constant
temperatur
rtsiba
detect
rv
clinic
sampl
high
analyt
sensit
specif
compar
diagnost
rtqpcr
method
use
posit
control
establish
analyt
sensit
rtsiba
assay
noncod
region
ncr
clone
respect
plasmid
eurofin
germani
plasmid
use
control
quantif
viral
rna
use
qrtpcr
total
microb
rhinovirus
commonli
found
respiratori
specimen
use
determin
analyt
specif
assay
total
respiratori
clinic
isol
rhinoviru
coronaviru
enteroviru
collect
univers
turku
turku
finland
total
retrospect
nasopharyng
np
swab
specimen
obtain
helsinki
univers
hospit
finland
posit
rv
specimen
handl
test
anonym
ethic
approv
well
patient
consent
obtain
collect
use
specimen
develop
diagnost
method
applic
clinic
isol
specimen
use
evalu
clinic
perform
rv
siba
rv
rtpcr
assay
specimen
obtain
use
accord
bioethic
polici
helsinki
univers
hospit
univers
turku
rna
extract
viral
strain
clinic
isol
np
fig
rhinoviru
amplif
reversetranscript
strand
invasionbas
amplif
rtsiba
rhinoviru
rna
revers
transcrib
cdna
revers
transcriptas
enzym
siba
amplif
requir
invas
oligonucleotid
io
two
targetspecif
primer
singl
strand
bind
protein
bind
oligonucleotid
order
reduc
format
secondari
structur
recombinas
protein
uvsx
coat
io
displac
bound
recombinaseio
complex
invad
separ
target
duplex
allow
targetspecif
primer
bind
extend
target
via
action
dna
polymeras
lead
synthesi
two
copi
target
duplex
continu
recombinasemedi
target
duplex
separ
dna
polymeras
extens
process
lead
exponenti
amplif
isotherm
condit
specimen
use
qiaamp
viral
rna
mini
kit
qiagen
germani
dna
extract
microbi
strain
use
qiaamp
dna
mini
kit
qiagen
extract
conduct
accord
manufactur
protocol
rv
ncr
sequenc
retriev
genbank
align
identifi
conserv
region
rtsiba
assay
design
detect
approxim
nucleotid
conserv
ncr
rhinoviru
genom
conserv
ncr
rv
use
rtsiba
assay
also
select
suffici
mismatch
respect
enteroviru
ev
ncr
sequenc
allow
better
differenti
ev
rv
set
primer
invas
oligonucleotid
io
design
amplifi
target
region
rtsiba
assay
use
one
forward
primer
one
revers
primer
one
io
detect
serotyp
b
serotyp
rtsiba
oligonucleotid
approxim
ident
serotyp
c
rhinoviru
io
includ
polycytosin
nucleotid
polyc
noncomplementari
target
region
seed
region
promot
optim
coat
io
recombinas
eboigbodin
et
al
hoser
et
al
formosa
albert
furthermor
io
modifi
rna
nucleotid
order
prevent
io
dna
polymeras
extens
oligonucleotid
use
studi
purchas
integr
dna
technolog
leuven
belgium
primer
io
purifi
reversephas
hplc
page
respect
sequenc
oligonucleotid
use
studi
provid
tabl
rtsiba
reaction
perform
use
siba
reagent
kit
orion
diagnostica
oy
espoo
finland
addit
u
goscript
revers
transcriptas
promega
madison
usa
uvsx
use
mgml
mgml
respect
reaction
initi
mm
magnesium
acet
forward
revers
primer
use
final
concentr
nm
respect
siba
reaction
optim
rapid
detect
type
b
determin
optim
io
concentr
ratio
b
io
io
test
final
concentr
nm
optim
ratio
io
use
subsequ
rv
rtsiba
experi
siba
product
detect
use
sybr
green
dilut
thermo
fisher
scientif
waltham
usa
standard
siba
reaction
volum
includ
templat
reaction
incub
min
fluoresc
read
taken
interv
biorad
cfx
biorad
laboratori
melt
curv
profil
gener
amplif
reaction
verifi
reaction
product
specif
perform
rtsiba
assay
compar
highli
sensit
rtpcr
assay
detect
enteroand
rhinovirus
et
al
assay
use
entero
rhinovirusspecif
ncr
primer
rtpcr
follow
rhinovirusspecif
lna
probe
specif
detect
rhinovirus
onestep
rtpcr
reaction
perform
use
express
onestep
qrtpcr
supermix
kit
thermo
fisher
scientif
primer
probe
use
nm
nm
respect
reaction
product
detect
cfx
pcr
instrument
biorad
laboratori
finland
follow
thermal
cycl
protocol
use
min
cdna
synthesi
min
revers
transcript
udg
inactiv
cycl
pcr
amplif
rhino
rtsiba
use
two
set
oligonucleotid
one
rva
one
rvb
allow
detect
member
speci
rhinoviru
rhinoviru
b
within
reaction
tube
reason
set
oligonucleotid
particularli
io
could
compet
among
result
suboptim
amplif
condit
therefor
sought
determin
optim
concentr
rva
rvb
io
rvaio
rvbio
would
effici
amplifi
rva
rvb
rna
reaction
tube
end
conduct
rv
rtsiba
assay
use
nm
io
determin
effect
io
concentr
detect
time
rv
b
type
amount
time
requir
obtain
posit
result
copi
rva
rvb
rna
per
reaction
shown
fig
result
consid
posit
fluoresc
signal
exceed
background
signal
amount
time
obtain
posit
result
rva
decreas
ie
amplif
rate
faster
concentr
rvaio
increas
nm
howev
increas
concentr
rvaio
also
led
dramat
increas
time
taken
detect
rvb
viru
ie
amplif
rate
rvb
rna
slower
similarli
increas
rvbio
concentr
nm
decreas
detect
time
rvb
rna
increas
detect
time
rva
rna
result
suggest
rvaio
rvbio
compet
reaction
compon
base
optim
result
perform
subsequ
experi
use
rvaio
rvbio
final
concentr
nm
respect
concentr
allow
optim
detect
rva
b
reaction
tube
analyt
sensit
rv
siba
rtpcr
assay
tabl
oligonucleotid
use
rv
siba
assay
elucid
use
quantifi
rna
extract
rhinoviru
experi
perform
three
independ
replic
ad
serial
dilut
rna
copi
per
reaction
rna
dilut
perform
triplic
result
shown
fig
tabl
rv
siba
assay
detect
littl
copi
either
rhinoviru
b
rna
rv
siba
assay
detect
copi
rv
rna
less
min
comparison
lowest
concentr
rva
rvb
rna
detect
rtpcr
copi
respect
furthermor
perform
probit
regress
analysi
determin
limit
detect
lod
rv
rtsiba
rv
rtpcr
concentr
rv
rna
detect
time
serial
dilut
quantifi
rva
rna
rvb
rna
copi
use
rna
dilut
perform
use
eight
replic
lod
rv
rtsiba
rva
rna
rvb
rna
copi
per
reaction
respect
meanwhil
lod
rv
rtpcr
rva
rna
rvb
rna
copi
per
reaction
respect
thu
rv
rtsiba
assay
sensit
rv
rtpcr
detect
purifi
rv
rna
particularli
rva
rna
furthermor
time
posit
result
significantli
shorter
rv
rtsiba
rv
rtpcr
took
approxim
h
analyt
specif
rv
rtsiba
rvrtpcr
assay
determin
challeng
assay
dna
rna
extract
microbi
strain
commonli
found
respiratori
specimen
tabl
none
microb
detect
either
assay
indic
assay
highli
specif
detect
rv
compar
perform
rv
siba
rtpcr
assay
use
rna
extract
respiratori
clinic
isol
contain
rhinovirus
coronavirus
enterovirus
tabl
rv
siba
rtpcr
assay
detect
rv
clinic
isol
crossreact
coronavirus
enterovirus
rv
siba
assay
detect
rv
isol
wherea
rtpcr
detect
rv
isol
evalu
perform
rv
siba
rtpcr
assay
use
retrospect
np
specimen
previous
determin
posit
n
neg
n
rv
result
shown
tabl
rv
siba
assay
detect
rvposit
specimen
wherea
rv
rtpcr
detect
rvposit
specimen
none
neg
rv
np
specimen
detect
rv
siba
assay
base
comparison
previou
result
sensit
specif
rv
detect
ci
ci
respect
rv
siba
assay
ci
ci
respect
rv
rtpcr
assay
suggest
rv
siba
assay
specif
slightli
less
sensit
rv
rtpcr
detect
np
specimen
howev
rv
siba
assay
significantli
shorter
time
posit
result
rv
rtpcr
assay
tabl
diagnosi
rv
extrem
challeng
due
genet
serolog
variabl
among
numer
type
similar
enterovirus
price
lau
et
al
nucleic
acid
amplif
test
naat
ie
rtpcr
remain
sensit
method
rhinoviru
detect
phenomena
respons
inconsist
perform
previous
report
rv
rtpcr
assay
cassandra
et
al
furthermor
due
requir
thermal
cycl
instrument
skill
personnel
rtpcr
reaction
costli
altern
naat
techniqu
isotherm
nucleic
acid
amplif
test
inaat
aim
overcom
problem
expens
instrument
studi
develop
evalu
inaat
rtsiba
rapid
detect
rv
rtsiba
use
revers
transcriptas
recombinas
recombinaseco
oligonucleotid
catalyz
separ
specif
target
sequenc
within
rv
genom
setup
enabl
targetspecif
rv
primer
exponenti
amplifi
target
sequenc
isotherm
condit
method
previous
shown
rapid
highli
sensit
techniqu
detect
infecti
diseas
eboigbodin
et
al
eboigbodin
et
al
b
liikonen
et
al
et
al
rv
siba
assay
use
two
set
oligonucleotid
allow
detect
rva
rvb
singl
reaction
tube
compar
perform
rv
siba
assay
previous
publish
rv
rtpcr
method
et
al
found
rv
siba
assay
sensit
detect
low
copi
number
quantifi
rv
rna
rv
rtpcr
assay
addit
compar
perform
rv
siba
rv
rtpcr
assay
use
clinic
isol
np
specimen
np
specimen
sensit
specif
rv
siba
assay
respect
wherea
rv
rtpcr
assay
respect
thu
rv
siba
assay
exhibit
slightli
lower
sensit
rv
rtpcr
detect
rv
np
specimen
time
posit
result
significantli
shorter
rv
siba
rv
rtpcr
assay
loopmedi
isotherm
amplif
method
lamp
detect
rv
previous
report
guan
et
al
siba
lamp
display
similar
perform
respect
detect
rv
clinic
specimen
howev
siba
display
faster
detect
time
lamp
particularli
detect
rhinoviru
b
viru
result
rv
siba
rv
rtpcr
well
correl
howev
evalu
perform
rv
assay
necessari
test
larger
set
clinic
specimen
anoth
limit
rv
siba
assay
test
rvc
mainli
due
unavail
wellcharacter
rvc
type
oligonucleotid
use
assay
share
approxim
ident
suggest
assay
could
also
detect
rvc
type
howev
may
necessari
includ
addit
oligonucleotid
facilit
optimum
detect
rvc
rv
siba
assay
perform
low
constant
temperatur
reaction
perform
use
rel
small
inexpens
fluoresc
reader
shorter
detect
time
rv
siba
assay
along
compat
portabl
devic
facilit
time
diagnosi
infect
therebi
improv
patient
care
help
avoid
unnecessari
use
antibiot
work
fund
orion
diagnostica
oy
salw
research
program
get
done
finnish
fund
agenc
technolog
innov
grant
academi
finland
financi
support
academi
finland
vk
grant
number
rv
rhinoviru
cv
coronaviru
ev
enteroviru
ethic
approv
well
patient
consent
obtain
collect
use
specimen
develop
diagnost
method
applic
